Bausch Health Companies (TSE:BHC) Hits New 52-Week Low – What’s Next?

Bausch Health Companies Inc. (TSE:BHC) reached a new 52-week low on Wednesday . The company traded as low as C$6.71 and last traded at C$6.72, with a volume of 496491 shares. The stock had previously closed at C$6.93.

Bausch Health Companies Stock Down 3.0%

The company has a market cap of C$2.51 billion, a price-to-earnings ratio of -2.07, a PEG ratio of 0.21 and a beta of 0.94. The company has a current ratio of 1.32, a quick ratio of 0.58 and a debt-to-equity ratio of -1,009.96. The business has a fifty day moving average of C$7.51 and a two-hundred day moving average of C$8.22.

Bausch Health Companies (TSE:BHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported C$1.08 earnings per share for the quarter. The company had revenue of C$3.51 billion during the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%. As a group, equities analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 EPS for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.